AU2001249479A1 - Physically stabilized dry powder formulations - Google Patents

Physically stabilized dry powder formulations

Info

Publication number
AU2001249479A1
AU2001249479A1 AU2001249479A AU4947901A AU2001249479A1 AU 2001249479 A1 AU2001249479 A1 AU 2001249479A1 AU 2001249479 A AU2001249479 A AU 2001249479A AU 4947901 A AU4947901 A AU 4947901A AU 2001249479 A1 AU2001249479 A1 AU 2001249479A1
Authority
AU
Australia
Prior art keywords
dry powder
powder formulations
physically stabilized
stabilized dry
physically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249479A
Inventor
Sarvajna Dwivedi
Gary Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dura Pharmaceuticals Inc
Original Assignee
Dura Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dura Pharmaceuticals Inc filed Critical Dura Pharmaceuticals Inc
Publication of AU2001249479A1 publication Critical patent/AU2001249479A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
AU2001249479A 2000-04-11 2001-03-27 Physically stabilized dry powder formulations Abandoned AU2001249479A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54712500A 2000-04-11 2000-04-11
US09547125 2000-04-11
PCT/US2001/009711 WO2001076560A1 (en) 2000-04-11 2001-03-27 Physically stabilized dry powder formulations

Publications (1)

Publication Number Publication Date
AU2001249479A1 true AU2001249479A1 (en) 2001-10-23

Family

ID=24183431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249479A Abandoned AU2001249479A1 (en) 2000-04-11 2001-03-27 Physically stabilized dry powder formulations

Country Status (5)

Country Link
EP (1) EP1274400A1 (en)
JP (1) JP2004515260A (en)
AU (1) AU2001249479A1 (en)
CA (1) CA2404645A1 (en)
WO (1) WO2001076560A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004048389A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modification of surfaces of lactose as adjuvant for use with powder inhalants
DE102004048390A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg New powder inhalants based on modified lactose mixtures as adjuvant
NZ556709A (en) 2005-02-10 2009-09-25 Glaxo Group Ltd Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
DE102006030166A1 (en) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg temper
JP2010501520A (en) * 2006-08-22 2010-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Inhalable powder formulation containing enantiomerically pure beta agonist
LT3191081T (en) 2014-09-09 2020-07-10 Vectura Limited Formulation comprising glycopyrrolate, method and apparatus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003197A1 (en) * 1985-11-29 1987-06-04 Fisons Plc Pharmaceutical composition including sodium cromoglycate
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers

Also Published As

Publication number Publication date
EP1274400A1 (en) 2003-01-15
JP2004515260A (en) 2004-05-27
WO2001076560A1 (en) 2001-10-18
CA2404645A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2002333644A1 (en) Dry powder medicament formulations
AU2001233201A1 (en) Dry powder inhaler
AU2001243611A1 (en) Stabilized dry powder formulations
AU2001294192A1 (en) Solid preparations
AU2001233738A1 (en) Improved paste formulations
AU2001279972A1 (en) Pesticidal formulations
AU2001267860A1 (en) Cellulose powder
AU6310000A (en) Aerosol formulations
SI1294421T1 (en) Dry Powder Inhaler
AU2001282877A1 (en) Cosmetic compositions
AU2002212254A1 (en) Microcapsule powder
AU2764501A (en) Dry erase member
AU2001236005A1 (en) Preparations stabilized over long time
AU5139600A (en) Nutritional formulations
AU2002218751A1 (en) Stable radiopharmaceutical compositions
AU2001295657A1 (en) Formulation containing wax-esters
AU2001282617A1 (en) Compositions for external preparations
AU2001265919A1 (en) Cosmetic compositions
AU2001262691A1 (en) Cosmetic preparation
AU2001267707A1 (en) Antiperspirant formulations
GB9916316D0 (en) Dry powder compositions
AUPQ147699A0 (en) Sunscreen formulations
GB0003935D0 (en) Formulation for dry powder inhaler
AU2001267693A1 (en) Antiperspirant formulations
AU2001249479A1 (en) Physically stabilized dry powder formulations